| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 138, 111-117, Copyright © 1991 by American Society for Investigative Pathology
REGULAR ARTICLES |
J Grondahl-Hansen, E Ralfkiaer, LT Kirkeby, P Kristensen, LR Lund and K Dano
Department of Biochemistry and Nutrition, Technical University of Denmark, Lyngby.
Human colon adenocarcinomas and adjacent normal colon tissues were stained immunohistochemically with three different monoclonal antibodies and one preparation of polyclonal antibodies against each of the two plasminogen activators, uPA (urokinase type) and tPA (tissue type). The staining patterns seen with the respective sets of antibodies were identical. In all of 10 cases, staining for uPA in the normal colon tissue was confined to scattered fibroblastlike cells in the lamina propria. Other cells, including epithelial and endothelial cells, were uPA negative. All the tumor infiltrates contained many more uPA-positive cells than the normal tissues, but the staining was confined to fibroblastlike cells and endothelial cells in the tumor stroma, while no staining of the malignant epithelial cells was detected. Analysis for uPA by enzyme-linked immunosorbent assay (ELISA) in four cases showed an average uPA content of 0.15 ng uPA/mg protein in the normal colon tissues and 1.6 ng uPA/mg protein in the tumors. Tissue-type plasminogen activator immunoreactivity was confined to endothelial cells in both the normal colon tissue and in the colon carcinomas. These findings may indicate that colon cancer cells recruit stromal cells to produce uPA involved in degradation of the extracellular matrix during invasive growth.
This article has been cited by other articles:
 |
|
 |
|
  G. Sonvilla, S. Allerstorfer, S. Stattner, J. Karner, M. Klimpfinger, H. Fischer, B. Grasl-Kraupp, K. Holzmann, W. Berger, F. Wrba, et al. FGF18 in colorectal tumour cells: autocrine and paracrine effects Carcinogenesis, January 1, 2008; 29(1): 15 - 24. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Illemann, N. Bird, A. Majeed, M. Sehested, O. D. Laerum, L. R. Lund, K. Dano, and B. S. Nielsen MMP-9 Is Differentially Expressed in Primary Human Colorectal Adenocarcinomas and Their Metastases Mol. Cancer Res., May 1, 2006; 4(5): 293 - 302. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Rono, J. Romer, S. Liu, T. H. Bugge, S. H. Leppla, and P. E.G. Kristjansen Antitumor efficacy of a urokinase activation-dependent anthrax toxin Mol. Cancer Ther., January 1, 2006; 5(1): 89 - 96. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Pakneshan, M. Szyf, and S. A. Rabbani Methylation and inhibition of expression of uPA by the RAS oncogene: divergence of growth control and invasion in breast cancer cells Carcinogenesis, March 1, 2005; 26(3): 557 - 564. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Rosmann, D. Hahn, D. Lottaz, M.-N. Kruse, W. Stocker, and E. E. Sterchi Activation of Human Meprin-alpha in a Cell Culture Model of Colorectal Cancer Is Triggered by the Plasminogen-activating System J. Biol. Chem., October 18, 2002; 277(43): 40650 - 40658. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E A Baker, F G Bergin, and D J Leaper Plasminogen activator system, vascular endothelial growth factor, and colorectal cancer progression Mol. Pathol., December 1, 2000; 53(6): 307 - 312. [Abstract] [Full Text]
|
|
|
|
 |
|
 Y. Friedmann, I. Vlodavsky, H. Aingorn, A. Aviv, T. Peretz, I. Pecker, and O. Pappo Expression of Heparanase in Normal, Dysplastic, and Neoplastic Human Colonic Mucosa and Stroma : Evidence for Its Role in Colonic Tumorigenesis Am. J. Pathol., October 1, 2000; 157(4): 1167 - 1175. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. R. Harvey, S. N. J. Sait, Y. Xu, J. L. Bailey, R. M. Penetrante, and G. Markus Demonstration of Urokinase Expression in Cancer Cells of Colon Adenocarcinomas by Immunohistochemistry and in Situ Hybridization Am. J. Pathol., October 1, 1999; 155(4): 1115 - 1120. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P R Gibson, I Birchall, O Rosella, V Albert, C F Finch, D H Barkla, and G P Young Urokinase and the intestinal mucosa: evidence for a role in epithelial cell turnover Gut, November 1, 1998; 43(5): 656 - 663. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Yu, J. Kim, and L. Ossowski Reduction in Surface Urokinase Receptor Forces Malignant Cells into a Protracted State of Dormancy J. Cell Biol., May 5, 1997; 137(3): 767 - 777. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. W. Visscher, B. Sloane, W. Sakr, M. Sameni, D. Weaver, D. Bouwman, and J. D. Crissman Clinicopathologic Significance of Cathepsin B and Urokinase-type Plasminogen Activator Immunostaining in Colorectal Adenocarcinoma International Journal of Surgical Pathology, April 1, 1994; 1(4): 227 - 234. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
